TIDMDPH

RNS Number : 6544Z

Dechra Pharmaceuticals PLC

15 September 2022

Thursday, 15 September 2022

Dechra(R) Pharmaceuticals PLC

(the Company)

2022 Annual Report Posting Date

The Company announced last week (on 6 September) that the 2022 Annual Report and Accounts and related documents would be mailed to registered shareholders on the Monday, 19 September 2022. However, as this day is being marked as a Bank Holiday in the UK, the Company wishes to advise shareholders that we now expect to mail all documentation on Tuesday 20 September 2022.

At the same time, and in accordance with Listing Rule 9.6.1 a copy of all these documents will be submitted to the National Storage Mechanism and will be available for viewing.

The 2022 Annual Report and Accounts is already available to view and download from the Company's investor website.

For further information, please contact:

Melanie Hall, Company Secretary

Dechra Pharmaceuticals PLC

Telephone: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide.

For more information please visit: www.dechra.com

LEI: 213800J4UVB5OWG8VX82

Trademarks

Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSUVUSRUBUKAAR

(END) Dow Jones Newswires

September 15, 2022 10:28 ET (14:28 GMT)

Dechra Pharmaceuticals (LSE:DPH)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Dechra Pharmaceuticals.
Dechra Pharmaceuticals (LSE:DPH)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Dechra Pharmaceuticals.